Related Experiment Video
Updated: May 10, 2026
10:17
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
Published on: November 15, 2024
Implementation and outcomes of a live continuing education program on pharmacogenomics
Grace M Kuo1, Kelly C Lee, Joseph D Ma
1Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive MC 0719, La Jolla, CA 92093-0719, USA. gmkuo@ucsd.edu
Pharmacogenomics
|June 11, 2013
Summary
Pharmacists showed significant improvements in pharmacogenomics knowledge and patient counseling skills after attending continuing education lectures. The program enhanced their ability to address pharmacogenomics testing effectively.
Area of Science:
- Pharmacogenomics
- Continuing Education
- Pharmacy Practice
Background:
- Pharmacogenomics is crucial for personalized medicine.
- Pharmacists require specialized education to integrate pharmacogenomics into practice.
- Current educational gaps hinder pharmacists' confidence in applying pharmacogenomics.
Purpose of the Study:
- To assess the effectiveness of a pharmacogenomics education program for pharmacists.
- To evaluate pharmacists' knowledge, self-efficacy, and attitudes towards pharmacogenomics.
- To measure the impact of continuing education on pharmacogenomics implementation.
Main Methods:
- Delivered pharmacogenomics continuing education lectures at pharmacy conferences.
- Collected program evaluations from 673 pharmacist participants.
- Assessed changes in knowledge, self-efficacy, and attitudes post-education.
Main Results:
- Significant improvements in pharmacogenomics knowledge and ability to address testing (p < 0.001).
- Over 50% reported likely or very likely self-efficacy in clinical application.
- High ratings for program usefulness, format, content, and audience response system.
Conclusions:
- Live continuing education at pharmacy conferences effectively increases pharmacists' pharmacogenomics knowledge.
- The program improved participants' overall ability to address pharmacogenomics testing with patients.
- Pharmacists demonstrated increased confidence and positive attitudes towards integrating pharmacogenomics into practice.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...